An investigation into the effect and mechanisms of action of nicotine in inflammatory bowel disease

Inflammation Research

Volumn 49, Issue 7, 2000, Pages 311-

  Sykes, A P ^a   Brampton, C ^a   Klee, S ^a   Chander, C L ^b   Whelan, C ^a   Parsons, M E ^a  

^a UNIVERSITY OF HERTFORDSHIRE   (United Kingdom)

^b UNIVERSITY OF BEDFORDSHIRE   (United Kingdom)

Author keywords

Inflammatory bowel disease; Nicotine; Sulphasalazine; TNBS; TNF

Indexed keywords

INDUCIBLE NITRIC OXIDE SYNTHASE; LEUKOTRIENE B4; NICOTINE; NITRIC OXIDE SYNTHASE; NONSTEROID ANTIINFLAMMATORY AGENT; NOS2 PROTEIN, RAT; NOS2A PROTEIN, HUMAN; PEROXIDASE; SALAZOSULFAPYRIDINE; TRINITROBENZENESULFONIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; BIOSYNTHESIS; CELL CULTURE; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; ENTERITIS; HUMAN; LEUKEMIA; MALE; METABOLISM; PATHOLOGY; RAT; WISTAR RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; HUMANS; INFLAMMATORY BOWEL DISEASES; LEUKEMIA; LEUKOTRIENE B4; MALE; NICOTINE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PEROXIDASE; RATS; RATS, WISTAR; SULFASALAZINE; TRINITROBENZENESULFONIC ACID; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034222072     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000110050597     Document Type: Article

References (30)

1. Bonapace CR, Mays DA. The effect of mesalamine and nicotine in the treatment of inflammatory bowel disease. Ann Pharmacother 1997; 31: 907-13.
2. Cohen RD, Hanauer SB. Nicotine in ulcerative colitis. How does it work and how can we use it? Clin Immunother 1996; 5: 169-74.
3. Birtwistle J. The role of cigarettes and nicotine in the onset and treatment of ulcerative colitis. Postgrad Med J 1996; 72: 714-8.
4. Louvet B, Buisine MP, Desreumaux P, Tremaine WJ, Aubert JP, Porchet N et al., Transdermal nicotine decreases mucosal IL-8 expression but has no effect on mucin gene expression in ulcerative colitis (UC). Gastroenterology 1998; 114: A1028.
5. Green JT, Thomas GAO, Rhodes J, Williams GT, Evans BK, Russell MAH et al. Nicotine enemas for active ulcerative colitis-a pilot study. Aliment Pharmacol Ther 1997; 11: 859-63.
6. Pullan RD, Rhodes J, Ganesh S, Mani V, Morris JS, Williams GT et al., Transdermal nicotine for active ulcerative-colitis. N Engl J Med 1994; 330: 811-5.
7. Lashner BA, Hanauer SB, Silverstein MD. Testing nicotine gum for ulcerative-colitis patients-experience with single-patient trials. Dig Dis Sci 1990; 35: 827-32.
8. Green JT, Rhodes J, Thomas GAO, Evans BK, Feyerabend C, Russell MAH et al. Nicotine carbomer enemas-pharmacokinetics of a revised formulation. Ital J Gastroenterol Hepatol 1998; 30: 260-5.
9. Madretsma S, Wolters LMM, van Dijk JPM, Tak CJAM, Feyerabend C, Wilson JHP et al. In-vivo effect of nicotine on cytokine production by human non-adherent mononuclear cells. Eur J Gastroenterol Hepatol 1996; 8: 1017-20.
10. Madretsma GS, Donze GJ, van Dijk APM, Tak CJAM, Wilson JHP, Zijlstra FJ. Nicotine inhibits the in-vitro production of interleukin 2 and tumour necrosis factor-α by human mononuclear cells. Immunopharmacology 1996; 35: 47-51.
11. Bhatti MA, Hodgson HJF. Nicotine down-regulates IL-8 production and tissue expression in inflammatory bowel disease (IBD). Gastroenterology 1997; 112: A934.
12. Qiu BS, Deng YK, Galeazzi F, Collins SM. Neural involvement in the bivalent action of nicotine on experimental colitis in rats. Gastroenterology 1997; 112: A1065.
13. Eliakim R, Karmeli F, Rachmilewitz D, Cohen P, Fich A. Effect of chronic nicotine administration on trinitrobenzene sulphonic acid-induced colitis. Eur J Gastroenterol Hapatol 1998; 10: 1013-19.
14. Seow WK, Thong YH, Nelson RD, Macfarlane GD, Herzberg MC. Nicotine-induced release of elastase and eicosanoids by human neutrophils. Inflammation 1994; 18: 119-27.
15. Morris GP, Beck PL, Herridge MS, Depew WT, Szewczuk MR, Wallace JL. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 1989; 96: 795-803.
16. Zingarelli B, Squadrito F, Graziani P, Camerini R, Caputi AP. Effects of zileuton, a new 5-lipoxygenase inhibitor, in experimentally induced colitis in rats. Agents Actions 1993; 39: 150-6.
17. Boughton-Smith NK, Wallace JL, Morris GP, Whittle BJR. The effect of anti-inflammatory drugs on eicosanoid formation in a chronic model of inflammatory bowel disease in the rat. Br J Pharmacol 1988; 94: 65-72.
18. Sykes AP, Bhogal R, Brampton C, Chander C, Whelan C, Parsons ME et al. The effect of an inhibitor of matrix metalloproteinases on colonic inflammation in a TNBS rat model of inflammatory bowel disease. Aliment Pharmacol Ther 1999; 13: 1535-42.
19. Feyerabend C, Russell MAH. A rapid gas-liquid chromatographic method for the determination of cotinine and nicotine in biological fluids. J Pharm Pharmacol 1990; 42: 450-2.
20. Galeazzi F, Blennerhassett PA, Qiu BS, Otis J, Barbara G, O'Byrne PM et al. Cigarette smoking aggravates experimental colitis in the rat. Gastroenterology 1997; 112: A978.
21. Galeazzi F, Blennerhassett PA, Qiu B, O'Byrne PM, Collins SM. Cigarette smoke aggravates experimental colitis in rats. Gatsroenterology 1999; 117: 877-83.
22. Guo X, Wang WP, Ko JKS, Cho CH. Involvement of neutrophils and free radicals in the potentiating effects of passive cigarette smoking on inflammatory bowel disease in rats. Gastroenterology 1999; 117: 884-92.
23. Zijlstra FJ, Srivastava ED, Rhodes M, Van Dijk APM, Fogg F, Samson HJ et al. Effect of nicotine on rectal mucus and mucosal eicosanoids. Gut 1994; 35: 247-51.
24. Aoshiba K, Nagai A, Yasui S, Konno K. Nicotine prolongs neutrophil survival by suppressing apoptosis. J Lab Clin Med 1996; 127: 186-94.
25. Motley RJ, Rhodes J, Williams G, Tavares IA, Bennett A. Smoking, eicosanoids and ulcerative-colitis. J Pharm Pharmacol 1990; 42: 288-9.
26. Bugajski J, Gadekmichalska A, Borycz J, Glod R. Effect of indomethacin on nicotine-induced ACTH and corticosterone response. J Physiol Pharmacol 1998; 49, 165-73.
27. Targan SR, Hanuaer SB, van Deventer SJH, Mayer L, Present DH, Braakman T et al. A short-term study of chimeric monoclonal antibody cA2 to tumour necrosis factor for Crohn's disease. N Engl J Med 1997; 337: 1029-35.
28. Van Dijk JPM, Madretsma S, Keuskamp ZJ, Zijlstra FJ. Nicotine inhibits cytokine synthesis by mouse colonic mucosa. Eur J Pharmacol 1995; 278: R11-2.
29. Ko JS, Guo X, Cho CH. The therapeutic intervention of hapten (DNBS) induced ulcerative colitis by passive cigarette smoking in rats. Gastroenterology 1999; 116: G3256.
30. Davies BD, Hoss W, Lin J-P, Lionetti F. Evidence for a non-cholinergic nicotine receptor on human phagocytic leukocytes. Mol Cell Biochem 1982; 44: 23-31.